{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:02:07Z","timestamp":1772236927691,"version":"3.50.1"},"reference-count":41,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2131\/jts.43.395","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T18:34:51Z","timestamp":1528137291000},"page":"395-405","source":"Crossref","is-referenced-by-count":10,"title":["Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis"],"prefix":"10.2131","volume":"43","author":[{"given":"Keisuke","family":"Goda","sequence":"first","affiliation":[{"name":"Toxicology Research Lab., Central Pharmaceutical Research Institute, JAPAN TOBACCO Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Medicinal Safety Science, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyotaka","family":"Muta","sequence":"additional","affiliation":[{"name":"Toxicology Research Lab., Central Pharmaceutical Research Institute, JAPAN TOBACCO Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Toxicology Research Lab., Central Pharmaceutical Research Institute, JAPAN TOBACCO Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Medicinal Safety Science, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Sugai","sequence":"additional","affiliation":[{"name":"Toxicology Research Lab., Central Pharmaceutical Research Institute, JAPAN TOBACCO Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abdel-Dayem, M.A., Elmarakby, A.A., Abdel-Aziz, A.A., Pye, C., Said, S.A. and El-Mowafy, A.M. (2014): Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen. Drugs R D., <b>14<\/b>, 85-94.","DOI":"10.1007\/s40268-014-0042-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Aires, C.C., Ijlst, L., Stet, F., Prip-Buus, C., de Almeida, I.T., Duran, M., Wanders, R.J. and Silva, M.F. (2010): Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem. Pharmacol., <b>79<\/b>, 792-799.","DOI":"10.1016\/j.bcp.2009.10.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Blumberg, P.M., Acs, G., Acs, P., Areces, L.B., Kazanietz, M.G., Lewin, N.E. and Szallasi, Z. (1995): Protein kinase C in cell signaling: strategies for the development of selective inhibitors. Agents Actions Suppl., <b>47<\/b>, 87-100.","DOI":"10.1007\/978-3-0348-7343-7_7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chapman, A., Keane, P.E., Meldrum, B.S., Simiand, J. and Vernieres, J.C. (1982): Mechanism of anticonvulsant action of valproate. Prog. Neurobiol., <b>19<\/b>, 315-359.","DOI":"10.1016\/0301-0082(82)90010-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chavez-Blanco, A., Segura-Pacheco, B., Perez-Cardenas, E., Taja-Chayeb, L., Cetina, L., Candelaria, M., Cantu, D., Gonzalez-Fierro, A., Garcia-Lopez, P., Zambrano, P., Perez-Plasencia, C., Cabrera, G., Trejo-Becerril, C., Angeles, E. and Duenas-Gonzalez, A. (2005): Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study. Mol. Cancer, <b>4<\/b>, 22.","DOI":"10.1186\/1476-4598-4-22"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cheng, J., Ma, X., Krausz, K.W., Idle, J.R. and Gonzalez, F.J. (2009): Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity. Drug Metab. Dispos., <b>37<\/b>, 1611-1621.","DOI":"10.1124\/dmd.109.027565"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Choi, Y.J., Lee, C.H., Lee, K.Y., Jung, S.H. and Lee, B.H. (2015): Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice. Toxicol. Sci., <b>145<\/b>, 273-282.","DOI":"10.1093\/toxsci\/kfv049"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Goda, K., Takahashi, T., Kobayashi, A., Shoda, T., Kuno, H. and Sugai, S. (2016): Usefulness of <i>in vitro<\/i> combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury. J. Toxicol. Sci., <b>41<\/b>, 605-615.","DOI":"10.2131\/jts.41.605"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Goda, K., Kobayashi, A., Takahashi, A., Takahashi, T., Saito, K., Maekawa, K., Saito, Y. and Sugai, S. (2017): Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans. Int. J. Mol. Sci., <b>18<\/b>, E810.","DOI":"10.3390\/ijms18040810"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Goodyear, O., Agathanggelou, A., Novitzky-Basso, I., Siddique, S., McSkeane, T., Ryan, G., Vyas, P., Cavenagh, J., Stankovic, T., Moss, P. and Craddock, C. (2010): Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Blood, <b>116<\/b>, 1908-1918.","DOI":"10.1182\/blood-2009-11-249474"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Gudbrandsen, O.A., Rost, T.H. and Berge, R.K. (2006): Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver. J. Lipid Res., <b>47<\/b>, 2223-2232.","DOI":"10.1194\/jlr.M600148-JLR200"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Han, X. and Gross, R.W. (2003): Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res., <b>44<\/b>, 1071-1079.","DOI":"10.1194\/jlr.R300004-JLR200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hannun, Y.A. and Linardic, C.M. (1993): Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim. Biophys. Acta, <b>1154<\/b>, 223-236.","DOI":"10.1016\/0304-4157(93)90001-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Houjou, T., Yamatani, K., Imagawa, M., Shimizu, T. and Taguchi, R. (2005): A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and\/or reverse-phase liquid chromatography\/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom., <b>19<\/b>, 654-666.","DOI":"10.1002\/rcm.1836"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ishikawa, M., Maekawa, K., Saito, K., Senoo, Y., Urata, M., Murayama, M., Tajima, Y., Kumagai, Y. and Saito, Y. (2014): Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects\u2019 gender and age. PLoS One, <b>9<\/b>, e91806.","DOI":"10.1371\/journal.pone.0091806"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ishikawa, M., Saito, K., Yamada, H., Nakatsu, N., Maekawa, K. and Saito, Y. (2016): Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats. Lipids Health Dis., <b>15<\/b>, 74.","DOI":"10.1186\/s12944-016-0244-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kesterson, J.W., Granneman, G.R. and Machinist, J.M. (1984): The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology, <b>4<\/b>, 1143-1152.","DOI":"10.1002\/hep.1840040609"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kotronen, A., Sepp\u00e4nen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeep\u00e4\u00e4, A.L., Yki-J\u00e4rvinen, H. and Oresic, M. (2010): Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring), <b>18<\/b>, 937-944.","DOI":"10.1038\/oby.2009.326"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Labbe, G., Pessayre, D. and Fromenty, B. (2008): Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam. Clin. Pharmacol., <b>22<\/b>, 335-353.","DOI":"10.1111\/j.1472-8206.2008.00608.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Le Dinh, T., Freneaux, E., Labbe, G., Letteron, P., Degott, C., Geneve, J., Berson, A., Larrey, D. and Pessayre, D. (1988): Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J. Pharmacol. Exp. Ther., <b>247<\/b>, 745-750.","DOI":"10.1016\/S0022-3565(25)13428-9"},{"key":"21","first-page":"870","year":"1982","unstructured":"Lewis, J.H., Zimmerman, H.J., Garrett, C.T. and Rosenberg, E. (1982): Valproate-induced hepatic steatogenesis in rats. Hepatology, <b>2<\/b>, 870-873.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Luiken, J.J., Niessen, H.E., Coort, S.L., Hoebers, N., Coumans, W.A., Schwenk, R.W., Bonen, A. and Glatz, J.F. (2009): Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition <i>in vivo<\/i> does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem. J., <b>419<\/b>, 447-455.","DOI":"10.1042\/BJ20082159"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Ma, J., Yu, J., Su, X., Zhu, C., Yang, X., Sun, H., Chen, D., Wang, Y., Cao, H. and Lu, J. (2014): UPLC-MS-based serum metabonomics for identifying acute liver injury biomarkers in Chinese miniature pigs. Toxicol. Lett., <b>225<\/b>, 358-366.","DOI":"10.1016\/j.toxlet.2014.01.008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"McCarthy, T.C., Pollak, P.T., Hanniman, E.A. and Sinal, C.J. (2004): Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-\u03b1 target gene activation. J. Pharmacol. Exp. Ther., <b>311<\/b>, 864-873.","DOI":"10.1124\/jpet.104.072785"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Men\u00e9, P., Simonson, M.S. and Dunn, M.J. (1989): Phospholipids in signal transduction of mesangial cells. Am. J. Physiol., <b>256<\/b>, F375-F386.","DOI":"10.1152\/ajprenal.1989.256.3.F375"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Mohanty, A. and McBride, H.M. (2013): Emerging roles of mitochondria in the evolution, biogenesis, and function of peroxisomes. Front. Physiol., <b>4<\/b>, 268.","DOI":"10.3389\/fphys.2013.00268"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Mortuza, G.B., Neville, W.A., Delaney, J., Waterfield, C.J. and Camilleri, P. (2003): Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats. Biochim. Biophys. Acta, <b>1631<\/b>, 136-146.","DOI":"10.1016\/S1388-1981(02)00361-X"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Pettus, B.J., Chalfant, C.E. and Hannun, Y.A. (2004): Sphingolipids in inflammation: roles and implications. Curr. Mol. Med., <b>4<\/b>, 405-418.","DOI":"10.2174\/1566524043360573"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Sahi, J., Grepper, S. and Smith, C. (2010): Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Curr. Drug Discov. Technol., <b>7<\/b>, 188-198.","DOI":"10.2174\/157016310793180576"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sahini, N., Selvaraj, S. and Borlak, J. (2014): Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome. PLoS One, <b>9<\/b>, e114085.","DOI":"10.1371\/journal.pone.0114085"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Saito, K., Ohno, Y. and Saito, Y. (2017): Enrichment of resolving power improves ion-peak quantification on a lipidomics platform. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., <b>1055-1056<\/b>, 20-28.","DOI":"10.1016\/j.jchromb.2017.04.019"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Saito, K., Maekawa, K., Ishikawa, M., Senoo, Y., Urata, M., Murayama, M., Nakatsu, N., Yamada, H. and Saito, Y. (2014): Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis. Toxicol. Sci., <b>141<\/b>, 377-386.","DOI":"10.1093\/toxsci\/kfu132"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Saito, K., Ueta, M., Maekawa, K., Sotozono, C., Kinoshita, S. and Saito, Y. (2016): Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis. PLoS One, <b>11<\/b>, e0167402.","DOI":"10.1371\/journal.pone.0167402"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sato, K., Ueda, Y., Ueno, K., Okamoto, K., Iizuka, H. and Katsuda, S. (2005): Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid. Virchows Arch., <b>447<\/b>, 996-999.","DOI":"10.1007\/s00428-005-0042-z"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Silva, M.F., Aires, C.C., Luis, P.B., Ruiter, J.P., IJlst, L., Duran, M., Wanders, R.J. and Tavares de Almeida, I. (2008): Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J. Inherit. Metab. Dis., <b>31<\/b>, 205-216.","DOI":"10.1007\/s10545-008-0841-x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Simon, D. and Penry, J.K. (1975): Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsia, <b>16<\/b>, 549-573.","DOI":"10.1111\/j.1528-1157.1975.tb04738.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Sobaniec-Lotowska, M.E. (1997): Effects of long-term administration of the antiepileptic drug--sodium valproate upon the ultrastructure of hepatocytes in rats. Exp. Toxicol. Pathol., <b>49<\/b>, 225-232.","DOI":"10.1016\/S0940-2993(97)80015-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Sugiura, A., Mattie, S., Prudent, J. and McBride, H.M. (2017): Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes. Nature, <b>542<\/b>, 251-254.","DOI":"10.1038\/nature21375"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Ulrich, R.G., Bacon, J.A., Brass, E.P., Cramer, C.T., Petrella, D.K. and Sun, E.L. (2001): Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem. Biol. Interact., <b>134<\/b>, 251-270.","DOI":"10.1016\/S0009-2797(01)00161-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Vamecq, J., Vallee, L., Fontaine, M., Lambert, D., Poupaert, J. and Nuyts, J.P. (1993): CoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl-CoA beta-oxidation. FEBS Lett., <b>322<\/b>, 95-100.","DOI":"10.1016\/0014-5793(93)81545-B"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Zhang, L., Chu, X., Wang, H., Xie, H., Guo, C., Cao, L., Zhou, X., Wang, G. and Hao, H. (2013): Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver. Eur. J. Pharmacol., <b>721<\/b>, 277-285.","DOI":"10.1016\/j.ejphar.2013.09.024"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/43\/6\/43_395\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T19:45:46Z","timestamp":1751658346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/43\/6\/43_395\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.43.395","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733487976.793547495","asserted-by":"object"}]},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}